trial · primary record
Nadofaragene Firadenovec
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 250 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Complete response |
| Registry ID | NCT06545955 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:52.134Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06545955
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Nadofaragene Firadenovec · compound